Search

Search Constraints

You searched for: Author/Creator Quick, Ann P.

Search Results

1. Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell‐derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia. Issue 13 (10th June 2021)

2. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study. (3rd August 2022)

3. Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging. Issue 2 (2nd February 2022)

4. Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction. (2021)

5. Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca2 + release. (15th December 2016)

6. Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca2 + release. (15th December 2016)

7. Long-Term Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma. (2021)

8. Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation. Issue 8 (20th August 2019)

9. Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. Issue 12 (22nd September 2020)

10. Oxidized CaMKII (Ca2+/Calmodulin-Dependent Protein Kinase II) Is Essential for Ventricular Arrhythmia in a Mouse Model of Duchenne Muscular Dystrophy. (April 2018)